Windtree Therapeutics Inc (WINT)
4.41
+0.11
(+2.56%)
USD |
NASDAQ |
May 17, 16:00
4.41
0.00 (0.00%)
After-Hours: 20:00
Windtree Therapeutics Cash from Operations (Quarterly): -3.567M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -3.567M |
| September 30, 2023 | -3.854M |
| June 30, 2023 | -3.497M |
| March 31, 2023 | -2.519M |
| December 31, 2022 | -3.38M |
| September 30, 2022 | -4.099M |
| June 30, 2022 | -5.258M |
| March 31, 2022 | -6.715M |
| December 31, 2021 | -4.932M |
| September 30, 2021 | -5.281M |
| June 30, 2021 | -7.403M |
| March 31, 2021 | -6.048M |
| December 31, 2020 | -4.539M |
| September 30, 2020 | -8.256M |
| June 30, 2020 | -7.038M |
| March 31, 2020 | -5.482M |
| December 31, 2019 | -5.459M |
| September 30, 2019 | -3.824M |
| June 30, 2019 | -6.621M |
| March 31, 2019 | -8.759M |
| December 31, 2018 | -6.191M |
| September 30, 2018 | -3.278M |
| June 30, 2018 | -3.766M |
| March 31, 2018 | -2.546M |
| December 31, 2017 | -4.808M |
| Date | Value |
|---|---|
| September 30, 2017 | -3.376M |
| June 30, 2017 | -5.529M |
| March 31, 2017 | -7.332M |
| December 31, 2016 | 60.23M |
| September 30, 2016 | -8.332M |
| June 30, 2016 | -9.127M |
| March 31, 2016 | -9.185M |
| December 31, 2015 | -7.646M |
| September 30, 2015 | -7.522M |
| June 30, 2015 | -9.676M |
| March 31, 2015 | -8.66M |
| December 31, 2014 | -10.08M |
| September 30, 2014 | -10.83M |
| June 30, 2014 | -9.979M |
| March 31, 2014 | -10.28M |
| December 31, 2013 | -10.03M |
| September 30, 2013 | -9.977M |
| June 30, 2013 | -10.21M |
| March 31, 2013 | -10.24M |
| December 31, 2012 | -9.063M |
| September 30, 2012 | -9.851M |
| June 30, 2012 | -8.424M |
| March 31, 2012 | -5.546M |
| December 31, 2011 | -5.524M |
| September 30, 2011 | -6.032M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-8.256M
Minimum
Sep 2020
-2.519M
Maximum
Mar 2023
-5.146M
Average
-5.258M
Median
Jun 2022
Cash from Operations (Quarterly) Benchmarks
| Lexicon Pharmaceuticals Inc | -55.13M |
| AIM ImmunoTech Inc | -9.758M |
| Perspective Therapeutics Inc | -9.008M |
| Protalix BioTherapeutics Inc | 4.188M |
| Armata Pharmaceuticals Inc | -10.58M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Financing (Quarterly) | 0.521M |
| Free Cash Flow | -13.45M |
| Free Cash Flow Per Share (Quarterly) | -11.86 |
| Free Cash Flow Yield | -1.42K% |